Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Bush

Showing results (391-400 of 517) with videos related to

Pageof 52
Sort By:
Experimental Gerontology|December 8, 2004
Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesisAlpaslan Dedeoglu, Kerry Cormier, Sandra Payton, et al.
Molecular Neurobiology|August 15, 2019
Correction to: Amyloid Precursor Protein Mediates Neuronal Protection from Rotenone ToxicityKathryn Cimdins, Hayley S Waugh, Vicki Chrysostomou, et al.
ACS Chemical Neuroscience|January 15, 2015
Decreased plasma iron in Alzheimer's disease is due to transferrin desaturationDominic J Hare, James D Doecke, Noel G Faux, et al.
Journal of Alzheimer'S Disease : JAD|January 11, 2013
Decline in cognitive function over 18 months in healthy older adults with high amyloid-βKathryn A Ellis, Yen Ying Lim, Karra Harrington, et al.
Biochemistry|July 1, 1999
The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reductionX Huang, C S Atwood, M A Hartshorn, et al.
Journal of Alzheimer'S Disease : JAD|February 23, 2017
Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL)Bárbara R Cardoso, Dominic J Hare, Ashley I Bush, et al.
Biomedicines|May 28, 2022
Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal StudyKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Journal of Psychiatric Research|March 23, 2019
Blood and brain protein levels of ubiquitin-conjugating enzyme E2K (UBE2K) are elevated in individuals with schizophreniaHannah Meiklejohn, Md Shaki Mostaid, Sandra Luza, et al.
Cell Death and Differentiation|April 22, 2022
Selective ferroptosis vulnerability due to familial Alzheimer's disease presenilin mutationsMark A Greenough, Darius J R Lane, Rachelle Balez, et al.
The Journal of Clinical Psychiatry|September 28, 2010
Qualitative methods in early-phase drug trials: broadening the scope of data and methods from an RCT of N-acetylcysteine in schizophreniaMichael Berk, Ahmed Munib, Olivia Dean, et al.
Pageof 52

Showing results (391-400 of 517) with videos related to

Sort By:
Pageof 52
Experimental Gerontology|December 8, 2004
Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesisAlpaslan Dedeoglu, Kerry Cormier, Sandra Payton, et al.
Molecular Neurobiology|August 15, 2019
Correction to: Amyloid Precursor Protein Mediates Neuronal Protection from Rotenone ToxicityKathryn Cimdins, Hayley S Waugh, Vicki Chrysostomou, et al.
ACS Chemical Neuroscience|January 15, 2015
Decreased plasma iron in Alzheimer's disease is due to transferrin desaturationDominic J Hare, James D Doecke, Noel G Faux, et al.
Journal of Alzheimer'S Disease : JAD|January 11, 2013
Decline in cognitive function over 18 months in healthy older adults with high amyloid-βKathryn A Ellis, Yen Ying Lim, Karra Harrington, et al.
Biochemistry|July 1, 1999
The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reductionX Huang, C S Atwood, M A Hartshorn, et al.
Journal of Alzheimer'S Disease : JAD|February 23, 2017
Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL)Bárbara R Cardoso, Dominic J Hare, Ashley I Bush, et al.
Biomedicines|May 28, 2022
Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal StudyKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Journal of Psychiatric Research|March 23, 2019
Blood and brain protein levels of ubiquitin-conjugating enzyme E2K (UBE2K) are elevated in individuals with schizophreniaHannah Meiklejohn, Md Shaki Mostaid, Sandra Luza, et al.
Cell Death and Differentiation|April 22, 2022
Selective ferroptosis vulnerability due to familial Alzheimer's disease presenilin mutationsMark A Greenough, Darius J R Lane, Rachelle Balez, et al.
The Journal of Clinical Psychiatry|September 28, 2010
Qualitative methods in early-phase drug trials: broadening the scope of data and methods from an RCT of N-acetylcysteine in schizophreniaMichael Berk, Ahmed Munib, Olivia Dean, et al.
Pageof 52